134 related articles for article (PubMed ID: 17868378)
1. Cell cycle-dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements.
Tschöp K; Engeland K
FEBS J; 2007 Oct; 274(20):5235-49. PubMed ID: 17868378
[TBL] [Abstract][Full Text] [Related]
2. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
Müller GA; Heissig F; Engeland K
Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
[TBL] [Abstract][Full Text] [Related]
3. Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter.
Wasner M; Haugwitz U; Reinhard W; Tschöp K; Spiesbach K; Lorenz J; Mössner J; Engeland K
Gene; 2003 Jul; 312():225-37. PubMed ID: 12909359
[TBL] [Abstract][Full Text] [Related]
4. The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription.
Müller GA; Engeland K
FEBS J; 2010 Feb; 277(4):877-93. PubMed ID: 20015071
[TBL] [Abstract][Full Text] [Related]
5. A CDE/CHR tandem element regulates cell cycle-dependent repression of cyclin B2 transcription.
Lange-zu Dohna C; Brandeis M; Berr F; Mössner J; Engeland K
FEBS Lett; 2000 Nov; 484(2):77-81. PubMed ID: 11068036
[TBL] [Abstract][Full Text] [Related]
6. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
8. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
9. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
[TBL] [Abstract][Full Text] [Related]
10. Identification of a genomic fragment that directs hematopoietic-specific expression of Rac2 and analysis of the DNA methylation profile of the gene locus.
Ladd PD; Butler JS; Skalnik DG
Gene; 2004 Oct; 341():323-33. PubMed ID: 15474314
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
[TBL] [Abstract][Full Text] [Related]
12. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.
Li F; Altieri DC
Cancer Res; 1999 Jul; 59(13):3143-51. PubMed ID: 10397257
[TBL] [Abstract][Full Text] [Related]
13. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
14. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.
Schroeder M; Mass MJ
Biochem Biophys Res Commun; 1997 Jun; 235(2):403-6. PubMed ID: 9199206
[TBL] [Abstract][Full Text] [Related]
15. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.
Gonzalgo ML; Hayashida T; Bender CM; Pao MM; Tsai YC; Gonzales FA; Nguyen HD; Nguyen TT; Jones PA
Cancer Res; 1998 Mar; 58(6):1245-52. PubMed ID: 9515812
[TBL] [Abstract][Full Text] [Related]
16. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.
Sarkar S; Abujamra AL; Loew JE; Forman LW; Perrine SP; Faller DV
Anticancer Res; 2011 Sep; 31(9):2723-32. PubMed ID: 21868513
[TBL] [Abstract][Full Text] [Related]
19. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
Inoue S; Oishi M
Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
